SC 13G 1 n3119_x1-13g.htm SCHEDULE 13G

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. )*

Jaguar Health, Inc.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

47010C607

(CUSIP Number)

March 4, 2022

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed:

☐ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 47010C607

(1)	Names of reporting persons: Joshua Mailman
(2)	Check the appropriate box if a member of a group (see instructions) (a) ☐ (b) ☐
(3)	SEC use only
(4)	Citizenship or place of organization: United States

Number of

beneficially

owned by

each

reporting

person with

(5)

Sole voting power:

4,088,758

(6)

Shared voting power:

4,525,380

(7)

Sole dispositive power:

4,088,758

(8)

Shared dispositive power:

4,525,380

(9)	Aggregate amount beneficially owned by each reporting person: 8,614,138
(10)	Check if the aggregate amount in row (9) excludes certain shares (see instructions): ☐
(11)	Percent of class represented by amount in row (9): 11.1%
(12)	Type of reporting person (see instructions): IN

CUSIP No. 47010C607

(1)	Names of reporting persons: Joshua Mailman Foundation
(2)	Check the appropriate box if a member of a group (see instructions) (a) ☐ (b) ☐
(3)	SEC use only
(4)	Citizenship or place of organization: Delaware

Number of

beneficially

owned by

each

reporting

person with

(5)

Sole voting power:

(6)

Shared voting power:

4,366,665

(7)

Sole dispositive power:

(8)

Shared dispositive power:

4,366,665

(9)	Aggregate amount beneficially owned by each reporting person: 4,366,665
(10)	Check if the aggregate amount in row (9) excludes certain shares (see instructions): ☐
(11)	Percent of class represented by amount in row (9): 5.6%
(12)	Type of reporting person (see instructions): CO

Item 1(a). Name of issuer:

Jaguar Health, Inc.

Item 1(b). Address of issuer’s principal executive offices:

200 Pine Street, Suite 400

San Francisco, California

Item 2(a). Name of person filing:

This Schedule 13G is being filed by (i) Joshua Mailman and (ii) the Joshua Mailman Foundation, a Delaware corporation (the “Foundation”) (collectively, the “Reporting Persons”).

The Foundation is a private charitable foundation under 501(c)(3) of the Internal Revenue Code. Mr. Mailman is the President of the Foundation and by virtue of such position may be deemed to share beneficial ownership with the Foundation. Mr. Mailman disclaims beneficial ownership of the shares of Common Stock held by the Foundation.

Item 2(b). Address of principal business office or, if none, residence:

The principal business office of the Reporting Persons is:

c/o Citron Cooperman

50 Rockefeller Plaza, 4th Floor

New York, NY 10020

Item 2(c). Citizenship:

Joshua Mailman is a United States citizen.

The Foundation is a not for profit corporation organized in Delaware.

Item 2(d). Title of Class of Securities:

Common Stock, par value $0.0001 per share (“Common Stock”)

Item 2(e). CUSIP No.:

47010C607

Item 3.

Not Applicable.

Item 4. Ownership

On March 4, 2022, Mr. Mailman acquired shares of Common Stock that resulted in him becoming the beneficial owner of more than five percent of the Common Stock of the issuer.

On March 8, 2022, the Foundation acquired shares of Common Stock that resulted in it becoming the beneficial owner of more than five percent of the Common Stock of the issuer.

The ownership information below represents beneficial ownership by the Reporting Persons of the Common Stock of as of March 14, 2022, the initial due date of this Statement on Schedule 13G, based upon 77,053,990 shares of Common Stock outstanding as of March 10, 2022, as reported by the issuer in its Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed with the Securities and Exchange Commission on March 11, 2022.

Reporting Person	Amount beneficially owned		Percent of class			Sole power to vote or to direct the vote		Shared power to vote or to direct the vote			Sole power to dispose or to direct the disposition		Shared power to dispose or to direct the disposition
Joshua Mailman		8,614,138		11.2	%		4,088,758		4,525,380	*		4,088,758		4,525,380	*
Foundation		4,366,665		5.7	%		0		4,366,665			0		4,366,665

* includes 158,715 shares of Common Stock held by the EJM 2012 Trust; Monica Winsor, Mr. Mailman’s spouse, is the sole trustee of the EJM 2021 Trust

The ownership information below represents the beneficial ownership by the Reporting Persons of the Common Stock as of the filing date of this Statement on Schedule 13G based upon 77,858,506 shares of Common Stock outstanding as of April 14, 2022, as reported by the issuer in its proxy statement filed with the Securities and Exchange Commission on April 27, 2022.

Reporting Person	Amount beneficially owned		Percent of class			Sole power to vote or to direct the vote		Shared power to vote or to direct the vote			Sole power to dispose or to direct the disposition		Shared power to dispose or to direct the disposition
Joshua Mailman		8,614,138		11.1	%		4,088,758		4,525,380	*		4,088,758		4,525,380	*
Foundation		4,366,665		5.6	%		0		4,366,665			0		4,366,665

* includes 158,715 shares of Common Stock held by the EJM 2012 Trust; Monica Winsor, Mr. Mailman’s spouse, is the sole trustee of the EJM 2021 Trust

Item 5. Ownership of Five Percent or Less of a Class

Not Applicable.

Item 6. Ownership of More Than Five Percent on Behalf of Another Person

Not Applicable.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

Not Applicable.

Item 8. Identification and Classification of Members of the Group

Not Applicable.

Item 9. Notice of Dissolution of Group

Not Applicable.

Item 10. Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

EXHIBIT INDEX

Exhibit No.		Document

99.1		Joint Filing Agreement, dated May 10, 2022, among the Reporting Persons

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


May 10, 2022	By:	/s/ Joshua Mailman
	Name:	Joshua Mailman

	Joshua Mailman Foundation

May 10, 2022	By:	/s/ Joshua Mailman
	Name:	Joshua Mailman
	Title:	President

Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)

SEC Form SC 13G filed by Jaguar Health Inc.